Fulcrum Therapeutics (FULC) Shares Issued (2018 - 2026)

Fulcrum Therapeutics (FULC) has 9 years of Shares Issued data on file, last reported at $21000.0 in Q1 2026.

• Shares Issued for Q1 2026 came in at $21000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 million (up 282.47% YoY), and the FY2025 annual result was $4.2 million, up 51.75% from the prior year.
• Shares Issued slipped to $21000.0 in Q1 2026 per FULC's latest filing, from $3.8 million in the prior quarter.
• Over five years, Shares Issued peaked at $3.8 million in Q4 2025 and troughed at $21000.0 in Q1 2026.
• A 5-year average of $748666.7 and a median of $287000.0 in 2023 frame the typical range for Shares Issued.
• The sharpest annual moves came in 2022 and 2025: Shares Issued sank 96.08% in 2022, then jumped 4480.72% in 2025.
• A 5-year view of Shares Issued shows it stood at $267000.0 in 2022, then increased by 7.49% to $287000.0 in 2023, then sank by 71.08% to $83000.0 in 2024, then jumped by 4480.72% to $3.8 million in 2025, then plunged by 99.45% to $21000.0 in 2026.
• Business Quant data shows FULC's Shares Issued at $21000.0 in Q1 2026, $3.8 million in Q4 2025, and $64000.0 in Q3 2025.